Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP639506.RAuZYuvH3spIDmC03dObwjtPf5ht5osaS690S-6CtzalU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP639506.RAuZYuvH3spIDmC03dObwjtPf5ht5osaS690S-6CtzalU130_assertion type Assertion NP639506.RAuZYuvH3spIDmC03dObwjtPf5ht5osaS690S-6CtzalU130_head.
- NP639506.RAuZYuvH3spIDmC03dObwjtPf5ht5osaS690S-6CtzalU130_assertion description "[A significant expression decrease (> or =2) was found for all three genes early in tumor development: in 85% of cases for RBSP3; 73% for NPRL2 and 67% for RASSF1A (P < 0.001), more strongly pronounced in squamous cell than in adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP639506.RAuZYuvH3spIDmC03dObwjtPf5ht5osaS690S-6CtzalU130_provenance.
- NP639506.RAuZYuvH3spIDmC03dObwjtPf5ht5osaS690S-6CtzalU130_assertion evidence source_evidence_literature NP639506.RAuZYuvH3spIDmC03dObwjtPf5ht5osaS690S-6CtzalU130_provenance.
- NP639506.RAuZYuvH3spIDmC03dObwjtPf5ht5osaS690S-6CtzalU130_assertion SIO_000772 20193080 NP639506.RAuZYuvH3spIDmC03dObwjtPf5ht5osaS690S-6CtzalU130_provenance.
- NP639506.RAuZYuvH3spIDmC03dObwjtPf5ht5osaS690S-6CtzalU130_assertion wasDerivedFrom befree-20140225 NP639506.RAuZYuvH3spIDmC03dObwjtPf5ht5osaS690S-6CtzalU130_provenance.
- NP639506.RAuZYuvH3spIDmC03dObwjtPf5ht5osaS690S-6CtzalU130_assertion wasGeneratedBy ECO_0000203 NP639506.RAuZYuvH3spIDmC03dObwjtPf5ht5osaS690S-6CtzalU130_provenance.